News

Former President Uhuru Kenyatta has received an award from the World Health Organization (WHO). WHO formally recognized the ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
The World Health Organization (WHO) has issued new guidelines recommending the twice-yearly use of injectable lenacapavir ...
A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
A new global report from the World Health Organization (WHO) Commission on Social Connection reveals that one in six people ...
The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...
The facility is fully accredited by the World Health Organization (WHO) and recognized as one of the most advanced polio ...
Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...